Patents by Inventor Beatrice Diana DARIMONT

Beatrice Diana DARIMONT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20240132610
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
    Type: Application
    Filed: January 2, 2024
    Publication date: April 25, 2024
    Inventors: Barbora MALECOVA, Rob BURKE, Beatrice Diana DARIMONT, David SALA CANO
  • ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND USES THEREOF
    Publication number: 20240132611
    Abstract: Disclosed herein, in certain embodiments, are anti-transferrin receptor antibodies, anti-transferrin receptor antibody conjugates, and pharmaceutical compositions which comprise the anti-transferrin receptor antibodies or conjugates. In some embodiments, also disclosed herein are methods of delivering a payload utilizing an anti-transferrin receptor antibody described herein, and methods of treatment with use of an anti-transferrin receptor antibody described herein.
    Type: Application
    Filed: October 17, 2023
    Publication date: April 25, 2024
    Inventors: Beatrice Diana DARIMONT, Venkata Ramana DOPPALAPUDI, Rachel JOHNS
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20240124600
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
    Type: Application
    Filed: January 2, 2024
    Publication date: April 18, 2024
    Inventors: Barbora MALECOVA, Rob BURKE, Beatrice Diana DARIMONT, David SALA CANO
  • Compositions and methods of treating facioscapulohumeral muscular dystrophy
    Patent number: 11912779
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
    Type: Grant
    Filed: September 15, 2022
    Date of Patent: February 27, 2024
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Barbora Malecova, Rob Burke, Beatrice Diana Darimont, David Sala Cano
  • Compositions and methods of treating muscle atrophy and myotonic dystrophy
    Patent number: 11872287
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: January 16, 2024
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Andrew John Geall, Venkata Doppalapudi, David Sai-Ho Chu, Michael Caramian Cochran, Michael Hood, Beatrice Diana Darimont, Rob Burke, Yunyu Shi, Gulin Erdogan Marelius, Barbora Malecova
  • COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY
    Publication number: 20230398231
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1).
    Type: Application
    Filed: May 31, 2023
    Publication date: December 14, 2023
    Inventors: Venkata Ramana DOPPALAPUDI, Michael David HOOD, Rob BURKE, Michael Caramian COCHRAN, Beatrice Diana DARIMONT, Yunyu SHI, Gulin Erdogan MARELIUS, Barbora MALECOVA
  • Anti-transferrin receptor antibodies and uses thereof
    Patent number: 11834510
    Abstract: Disclosed herein, in certain embodiments, are anti-transferrin receptor antibodies, anti-transferrin receptor antibody conjugates, and pharmaceutical compositions which comprise the anti-transferrin receptor antibodies or conjugates. In some embodiments, also disclosed herein are methods of delivering a payload utilizing an anti-transferrin receptor antibody described herein, and methods of treatment with use of an anti-transferrin receptor antibody described herein.
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: December 5, 2023
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Beatrice Diana Darimont, Venkata Ramana Doppalapudi, Rachel Johns
  • ANTIBODY OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF INDUCING DMD EXON 44 SKIPPING
    Publication number: 20230364256
    Abstract: Disclosed herein are antibody oligonucleotide conjugates and pharmaceutical compositions that induce an alteration in an incorrectly spliced dystrophin mRNA transcript to induce exon 44 skipping. Also described herein include methods for treating muscle dystrophy including Duchenne muscular dystrophy that comprises administering antibody oligonucleotide conjugates or a pharmaceutical composition that induces alteration in an incorrectly spliced dystrophin mRNA transcript to induce exon 44 skipping.
    Type: Application
    Filed: April 4, 2023
    Publication date: November 16, 2023
    Inventors: Beatrice Diana DARIMONT, Usue ETXANIZ IRIGOIEN, Venkata Ramana DOPPALAPUDI, Michael Caramian COCHRAN, Isaac MARKS, Tyler ALBIN
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20230340474
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Application
    Filed: November 4, 2022
    Publication date: October 26, 2023
    Inventors: Barbora MALECOVA, Rob BURKE, David SALA CANO, Beatrice Diana DARIMONT
  • COMPOSITIONS AND METHODS OF TREATING POMPE DISEASE
    Publication number: 20230330246
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Pompe Disease.
    Type: Application
    Filed: May 4, 2021
    Publication date: October 19, 2023
    Inventors: Gulin Erdogan MARELIUS, Beatrice Diana DARIMONT, Yunyu SHI
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20230287420
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Application
    Filed: November 4, 2022
    Publication date: September 14, 2023
    Inventors: Barbora MALECOVA, Rob BURKE, David SALA CANO, Beatrice Diana DARIMONT
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20230279395
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Application
    Filed: November 4, 2022
    Publication date: September 7, 2023
    Inventors: Barbora MALECOVA, Rob BURKE, David SALA CANO, Beatrice Diana DARIMONT
  • Compositions and methods of treating muscle atrophy and myotonic dystrophy
    Patent number: 11712478
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: August 1, 2023
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Andrew John Geall, Venkata Ramana Doppalapudi, David Sai-Ho Chu, Michael Caramian Cochran, Michael Hood, Beatrice Diana Darimont, Rob Burke, Yunyu Shi, Gulin Erdogan Marelius, Barbora Malecova
  • Compositions and methods of treating muscle dystrophy
    Patent number: 11707532
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1).
    Type: Grant
    Filed: August 8, 2022
    Date of Patent: July 25, 2023
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Venkata Ramana Doppalapudi, Michael David Hood, Rob Burke, Michael Caramian Cochran, Beatrice Diana Darimont, Yunyu Shi, Gulin Erdogan Marelius, Barbora Malecova
  • COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY
    Publication number: 20230201362
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
    Type: Application
    Filed: September 27, 2022
    Publication date: June 29, 2023
    Inventors: Andrew John GEALL, Venkata DOPPALAPUDI, David Sai-Ho CHU, Michael Caramian COCHRAN, Michael HOOD, Beatrice Diana DARIMONT, Rob BURKE, Yunyu SHI, Gulin Erdogan MARELIUS, Barbora MALECOVA
  • COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY
    Publication number: 20230201363
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
    Type: Application
    Filed: November 17, 2022
    Publication date: June 29, 2023
    Inventors: Andrew John GEALL, Venkata DOPPALAPUDI, David Sai-Ho CHU, Michael Caramian COCHRAN, Michael HOOD, Beatrice Diana DARIMONT, Rob BURKE, Yunyu SHI, Gulin Erdogan MARELIUS, Barbora MALECOVA
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20230091801
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
    Type: Application
    Filed: September 15, 2022
    Publication date: March 23, 2023
    Inventors: Barbora MALECOVA, Rob BURKE, Beatrice Diana DARIMONT, David SALA CANO
  • Compositions and methods of treating muscle atrophy and myotonic dystrophy
    Patent number: 11583591
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: February 21, 2023
    Assignee: AVIDITY BIOSCIENCES LLC
    Inventors: Andrew John Geall, Venkata Ramana Doppalapudi, David Sai-Ho Chu, Michael Caramian Cochran, Michael Hood, Beatrice Diana Darimont, Rob Burke, Yunyu Shi, Gulin Erdogan Marelius, Barbora Malecova
  • COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY
    Publication number: 20230047754
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
    Type: Application
    Filed: August 25, 2022
    Publication date: February 16, 2023
    Inventors: Andrew John GEALL, Venkata DOPPALAPUDI, David Sai-Ho CHU, Michael Caramian COCHRAN, Michael HOOD, Beatrice Diana DARIMONT, Rob BURKE, Yunyu SHI, Gulin Erdogan MARELIUS, Barbora MALECOVA
  • Compositions and methods of treating muscle atrophy and myotonic dystrophy
    Patent number: 11576980
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: February 14, 2023
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Andrew John Geall, Venkata Ramana Doppalapudi, David Sai-Ho Chu, Michael Caramian Cochran, Michael Hood, Beatrice Diana Darimont, Rob Burke, Yunyu Shi, Gulin Erdogan Marelius, Barbora Malecova